EMEA-003316-PIP01-22 - paediatric investigation plan

Furosemide

Key facts

• Active substance:
  Furosemide
• Therapeutic area:
  Cardiovascular diseases
• Decision number:
  P/0315/2023
• PIP number:
  EMEA-003316-PIP01-22
• Pharmaceutical form(s):
  Age appropriate oral dosage formulation
• Condition(s) / indication(s):
  Treatment of fluid retention
• Route(s) of administration:
  Oral use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  09/08/2023
• Compliance check done:
  No

Decision

P/0315/2023 : EMA decision of 9 August 2023 on the agreement of a paediatric investigation plan for furosemide (EMEA-003316-PIP01-22)

Reference Number: EMA/336065/2023